NCT03236935 2026-04-09Phase Ib of L-NMMA and PembrolizumabThe Methodist Hospital Research InstitutePhase 1 Completed12 enrolled 15 charts
NCT05660083 2026-04-03Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)The Methodist Hospital Research InstitutePhase 2 Recruiting36 enrolled
NCT02834403 2023-12-15L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer PatientsThe Methodist Hospital Research InstitutePhase 1/2 Completed37 enrolled 20 charts